Intriguingly, FOXP1 is generally considered a tumor suppressor in the breast because high levels correlate with better prognosis, despite the finding that it promotes proliferation and migration of breast cancer cell lines (Oskay Halacli, 2017, Shigekawa et al., 2011, Xiao et al., 2016). Here, FOXP1 is linked to breast carcinoma.